Chenyao Wu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 29
- 3D Printing in Biomedical Research 4
-
- Advanced Nanomaterials in Catalysis 9
- MXene and MAX Phase Materials 8
- Co-authors
- Shige Wang (11 shared papers)Jiulong Zhao (9 shared papers)Jianlin Shi (10 shared papers)Changqing Ye (7 shared papers)Mingxian Huang (8 shared papers)Lisong Chen (4 shared papers)Yuting Zheng (7 shared papers)Deliang Xu (6 shared papers)
In The Last Decade
Chenyao Wu
53 papers receiving 1.8k citations
Chenyao Wu's Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 358
- Biomedical Engineering 985
- Materials Chemistry 845
- Renewable Energy, Sustainability and the Environment 256
- Molecular Medicine 68
Countries citing papers authored by Chenyao Wu
This map shows the geographic impact of Chenyao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyao Wu more than expected).
Fields of papers citing papers by Chenyao Wu
This network shows the impact of papers produced by Chenyao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyao Wu. The network helps show where Chenyao Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenyao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A nonferrous ferroptosis-like strategy for antioxidant inhibition–synergized nanocatalytic tumor therapeutics Hit paper breakdown → | 2021 | 217 |
| 2 | Photoredox‐Promoted Co‐Production of Dihydroisoquinoline and H2O2 over Defective Zn3In2S6 Hit paper breakdown → | 2023 | 159 |
| 3 | 2019 | 147 | |
| 4 | 2019 | 142 | |
| 5 | Ultrasound-Based Micro-/Nanosystems for Biomedical Applications Hit paper breakdown → | 2024 | 104 |
| 6 | 2022 | 101 | |
| 7 | 2018 | 101 | |
| 8 | 2017 | 88 | |
| 9 | 2018 | 66 | |
| 10 | 2003 | 62 | |
| 11 | 2019 | 58 | |
| 12 | 2017 | 58 | |
| 13 | 2019 | 58 | |
| 14 | 2022 | 57 | |
| 15 | 2021 | 51 | |
| 16 | 2022 | 33 | |
| 17 | 2021 | 31 | |
| 18 | 2023 | 31 | |
| 19 | 2024 | 25 | |
| 20 | 2018 | 21 |
About Chenyao Wu
Chenyao Wu is a scholar working on Biomedical Engineering, Materials Chemistry, Biomaterials, Molecular Biology and Cellular and Molecular Neuroscience, having authored 59 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (29 papers), Advanced Nanomaterials in Catalysis (9 papers), MXene and MAX Phase Materials (8 papers), Nanoparticle-Based Drug Delivery (6 papers), Neuroscience and Neural Engineering (4 papers), EEG and Brain-Computer Interfaces (4 papers), Cancer Research and Treatments (4 papers) and 3D Printing in Biomedical Research (4 papers). The work is most often cited by research in Biomaterials (358 citations), Biomedical Engineering (985 citations), Materials Chemistry (845 citations), Renewable Energy, Sustainability and the Environment (256 citations) and Molecular Medicine (68 citations). Chenyao Wu has collaborated with scholars based in China, Taiwan and Hong Kong. Frequent co-authors include Shige Wang, Jiulong Zhao, Jianlin Shi, Changqing Ye, Mingxian Huang, Lisong Chen, Yuting Zheng, Deliang Xu, Zhixin Chen and Han Lin. Their work appears in journals such as Advanced Science, Chemical Engineering Journal, Carbohydrate Polymers, Journal of the American Chemical Society and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.